These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 22072889)
1. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo. Feng L; Wu H; Ma P; Mumper RJ; Benhabbour SR Int J Nanomedicine; 2011; 6():2545-56. PubMed ID: 22072889 [TBL] [Abstract][Full Text] [Related]
2. Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancer. Feng L; Benhabbour SR; Mumper RJ Adv Healthc Mater; 2013 Nov; 2(11):1451-7. PubMed ID: 23606545 [TBL] [Abstract][Full Text] [Related]
3. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819 [TBL] [Abstract][Full Text] [Related]
4. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
5. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer. Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651 [TBL] [Abstract][Full Text] [Related]
6. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
7. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. Mi Y; Zhao J; Feng SS J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique. Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362 [TBL] [Abstract][Full Text] [Related]
9. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645 [TBL] [Abstract][Full Text] [Related]
11. Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Muthu MS; Kulkarni SA; Liu Y; Feng SS Nanomedicine (Lond); 2012 Mar; 7(3):353-64. PubMed ID: 22329606 [TBL] [Abstract][Full Text] [Related]
12. Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Mi Y; Liu Y; Feng SS Biomaterials; 2011 Jun; 32(16):4058-66. PubMed ID: 21396707 [TBL] [Abstract][Full Text] [Related]
13. Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Raju A; Muthu MS; Feng SS Expert Opin Drug Deliv; 2013 Jun; 10(6):747-60. PubMed ID: 23458409 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Choudhury H; Gorain B; Pandey M; Kumbhar SA; Tekade RK; Iyer AK; Kesharwani P Int J Pharm; 2017 Aug; 529(1-2):506-522. PubMed ID: 28711640 [TBL] [Abstract][Full Text] [Related]
16. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Gan CW; Feng SS Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685 [TBL] [Abstract][Full Text] [Related]
17. Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration. Qureshi OS; Kim HS; Zeb A; Choi JS; Kim HS; Kwon JE; Kim MS; Kang JH; Ryou C; Park JS; Kim JK J Microencapsul; 2017 May; 34(3):250-261. PubMed ID: 28557649 [TBL] [Abstract][Full Text] [Related]
18. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment. Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959 [TBL] [Abstract][Full Text] [Related]
19. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy. Huang L; Chen H; Zheng Y; Song X; Liu R; Liu K; Zeng X; Mei L Integr Biol (Camb); 2011 Oct; 3(10):993-1002. PubMed ID: 21938302 [TBL] [Abstract][Full Text] [Related]
20. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Cho HJ; Park JW; Yoon IS; Kim DD Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]